Shawn Lynch joined T2 Biosystems as Chief Financial Officer on May 16, 2016. Shawn has spent 20 years involved in strategic financial planning, business development and building strong global financial teams. He most recently served as Vice President & Chief Financial Officer for PerkinElmer’s Environmental Health business, a provider of analytical equipment, consumables and services to the food, environmental, and pharmaceutical end markets. Prior to PerkinElmer, Shawn was with General Electric from 2007 to 2014 in various roles of increasing responsibility with his last assignment serving as Global Controller, Measurement & Control. Prior to General Electric, Shawn spent three years in his first stint at PerkinElmer where he last served as the Director of Finance for the Bio-Discovery business. Shawn started his career at KPMG LLP where he last served as a Director in the firm’s M&A practice serving both public company and private equity clients. He is a certified public accountant and received a BS in accounting from Suffolk University.